drugset / Trial / NCT04848220

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention

NCT04848220

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether intravenous temanogrel is a safe and effective treatment for microvascular obstruction (MVO) in adult participants undergoing percutaneous coronary intervention (PCI).

Timeline

Start
2021-05-20
Primary completion
2022-08-23
Completion
2022-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Temanogrel Small molecule Intravenous